메뉴 건너뛰기




Volumn 28, Issue 9, 2014, Pages 1918-1922

Acceleration of Bcr-Abl + leukemia induced by deletion of JAK2

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; BETA INTERFERON; CD19 ANTIGEN; IMATINIB; JANUS KINASE 2; RUXOLITINIB;

EID: 84908264214     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.152     Document Type: Letter
Times cited : (11)

References (15)
  • 1
    • 84872065897 scopus 로고    scopus 로고
    • Jaks and stats in immunity, immunodeficiency, and cancer
    • O'Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med. 2013; 368: 161-170
    • (2013) N Engl J Med , vol.368 , pp. 161-170
    • O'Shea, J.J.1    Holland, S.M.2    Staudt, L.M.3
  • 4
    • 84859721377 scopus 로고    scopus 로고
    • Jak2 inhibition for the treatment of hematologic and solid malignancies
    • Harry BL, Eckhardt SG, Jimeno A. JAK2 inhibition for the treatment of hematologic and solid malignancies. Expert Opin Investig Drugs. 2012; 21: 637-655
    • (2012) Expert Opin Investig Drugs , vol.21 , pp. 637-655
    • Harry, B.L.1    Eckhardt, S.G.2    Jimeno, A.3
  • 5
    • 77949535491 scopus 로고    scopus 로고
    • Phase 2 study of cep-701, an orally available jak2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
    • Santos FPS, Kantarjian HM, Jain N, Manshouri T, Thomas DA, Garcia-Manero G., et al. Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis. Blood. 2010; 115: 1131-1136
    • (2010) Blood , vol.115 , pp. 1131-1136
    • Santos, F.P.S.1    Kantarjian, H.M.2    Jain, N.3    Manshouri, T.4    Thomas, D.A.5    Garcia-Manero, G.6
  • 7
    • 84875424883 scopus 로고    scopus 로고
    • Conditional deletion of jak2 reveals an essential role in hematopoiesis throughout mouse ontogeny: Implications for jak2 inhibition in humans
    • Park SO, Wamsley HL, Bae K, Hu Z, Li X, Choe S., et al. Conditional deletion of Jak2 reveals an essential role in hematopoiesis throughout mouse ontogeny: implications for Jak2 inhibition in humans. PLoS One. 2013; 8: e59675
    • (2013) PLoS One , vol.8 , pp. e59675
    • Park, S.O.1    Wamsley, H.L.2    Bae, K.3    Hu, Z.4    Li, X.5    Choe, S.6
  • 9
    • 77950684805 scopus 로고    scopus 로고
    • Preclinical characterization of the selective jak1/2 inhibitor incb018424: Therapeutic implications for the treatment of myeloproliferative neoplasms
    • Quintás-Cardama A, Vaddi K, Liu P, Manshouri T, Li J, Scherle PA., et al. Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood. 2010; 115: 3109-3117
    • (2010) Blood , vol.115 , pp. 3109-3117
    • Quintás-Cardama, A.1    Vaddi, K.2    Liu, P.3    Manshouri, T.4    Li, J.5    Scherle, P.A.6
  • 11
    • 33845239481 scopus 로고    scopus 로고
    • Stat3 governs distinct pathways in emergency granulopoiesis and mature neutrophils
    • Panopoulos AD, Zhang L, Snow JW, Jones DM, Smith AM, El Kasmi KC., et al. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood. 2006; 108: 3682-3690
    • (2006) Blood , vol.108 , pp. 3682-3690
    • Panopoulos, A.D.1    Zhang, L.2    Snow, J.W.3    Jones, D.M.4    Smith, A.M.5    El Kasmi, K.C.6
  • 12
    • 84918579424 scopus 로고    scopus 로고
    • Mutation of stat1/3 binding sites in gp130(fxxq) knock-in mice does not alter hematopoietic stem cell repopulation or self-renewal potential
    • Wang Z, Kang Z, Zhang Y, Tse W, Bunting KD. Mutation of STAT1/3 binding sites in gp130(FXXQ) knock-in mice does not alter hematopoietic stem cell repopulation or self-renewal potential. Am J Stem Cells. 2012; 1: 146-153
    • (2012) Am J Stem Cells , vol.1 , pp. 146-153
    • Wang, Z.1    Kang, Z.2    Zhang, Y.3    Tse, W.4    Bunting, K.D.5
  • 13
    • 84865735256 scopus 로고    scopus 로고
    • Heterodimeric jak-stat activation as a mechanism of persistence to jak2 inhibitor therapy
    • Koppikar P, Bhagwat N, Kilpivaara O, Manshouri T, Adli M, Hricik T., et al. Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy. Nature. 2012; 489: 155-159
    • (2012) Nature , vol.489 , pp. 155-159
    • Koppikar, P.1    Bhagwat, N.2    Kilpivaara, O.3    Manshouri, T.4    Adli, M.5    Hricik, T.6
  • 14
    • 84897020107 scopus 로고    scopus 로고
    • Important scaffold function of the janus kinase 2 uncovered by a novel mouse model harboring a jak2 activation loop mutation
    • Keil E, Finkenstädt D, Wufka C, Trilling M, Liebfried P, Strobl B., et al. Important scaffold function of the Janus kinase 2 uncovered by a novel mouse model harboring a Jak2 activation loop mutation. Blood. 2013; 123: 520-529
    • (2013) Blood , vol.123 , pp. 520-529
    • Keil, E.1    Finkenstädt, D.2    Wufka, C.3    Trilling, M.4    Liebfried, P.5    Strobl, B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.